Supplements

Highlights of the 7th Annual Community Oncology Conference

Highlights of the 7th Annual Community Oncology Conference A CME-Certified Supplement to Community Oncology(R), supported by educational grants from Celgene, Genentech, and Takeda Millennium. This is activity is also supported, in part, by an... »

Managing Patients With Heavily Pretreated Metastatic Breast Cancer: Balancing Efficacy and Safety

Managing Patients With Heavily Pretreated Metastatic Breast Cancer: Balancing Efficacy and Safety is a CME-Certified Supplement to Community Oncology®. This CME journal supplement is supported by an educational grant from Eisai Inc. and is jointly... »

Translational Genomic Research and the Treatment of Basal Cell Carcinoma

Translational Genomic Research and the Treatment of Basal Cell Carcinoma is a CME-Certified Supplement to Skin & Allergy News(R). This journal supplement is supported by an educational grant from Genentech and is jointly sponsored by University... »

Highlights of the 6th Annual Community Oncology Conference

A CME-Certified Supplement to Community Oncology (R), supported by educational grants from Bristol-Myers Squibb, Cephalon, Genentech, OSI Pharmaceuticals, Inc, Pfizer. This is activity is also supported, in part, by an educational donation provided... »

Highlights from the 6th Annual Chicago Supportive Oncology Conference

A CME-certified supplement to the Journal of Supportive Oncology. This supplement is supported by educational grants from Pfizer, Eisai, Meda, Purdue and an educational donation provided by Amgen Oncology. It is jointly sponsored by Northwestern... »

Therapeutic advances in non-small cell lung cancer: Highlights from the annual clinical cancer conferences

Treatment of advanced non-small cell lung cancer is in the midst of a paradigm shift. Recent efforts have focused on incorporating newer agents into first-line chemotherapy regimens and first-line maintenance therapy. These strategies have resulted... »

Best Practice Management of CINV in Oncology Patients: I. Physiology and Treatment of CINV

Chemotherapy-induced nausea and vomiting (CINV) involves multiple neurotransmitter and receptor systems; thus, its optimal treatment is likely to require a combination of therapies targeting multiple systems. Antiemetic regimens have evolved from... »